Cell Therapies’ Chief Scientific Officer, Dr Dominic Wall will participate in AusBiotech2015 as part of the Regenerative Medicine Forum. He is quoted today in an article by Sue Dunlevy highlighting the opportunities for improved cancer outcomes emerging from CAR-T research and the remaining challenges of manufacturing these patient specific therapies cost effectively. See the full article here: http://www.news.com.au/news/what-if-we-cant-afford-the-cure-for-cancer/story-fnihsrk2-1227542906466
